2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | 99.760 | 3.284 | 13.968 | 315.047 | 379.367 | 225.226 | 7.097 | 333.792 |
Total Income - EUR | - | - | 99.760 | 3.284 | 13.968 | 315.048 | 379.367 | 225.226 | 7.100 | 400.303 |
Total Expenses - EUR | - | - | 9.110 | 6.194 | 4.852 | 201.262 | 158.529 | 115.853 | 40.414 | 118.992 |
Gross Profit/Loss - EUR | - | - | 90.649 | -2.910 | 9.116 | 113.786 | 220.839 | 109.374 | -33.313 | 281.311 |
Net Profit/Loss - EUR | - | - | 89.652 | -2.943 | 8.976 | 110.636 | 216.352 | 107.121 | -33.384 | 277.308 |
Employees | - | - | 3 | 2 | 1 | 3 | 4 | 1 | 1 | 5 |
Check the financial reports for the company - Anmed Imob Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | - | 0 | 0 | 0 | 38.210 | 46.604 | 35.025 | 73.520 | 17.514 |
Current Assets | - | - | 89.696 | 86.695 | 90.780 | 261.369 | 431.356 | 142.507 | 33.727 | 389.765 |
Inventories | - | - | 0 | 0 | 0 | 18.393 | 27 | 27 | 27 | 27 |
Receivables | - | - | 89.514 | 82.088 | 80.948 | 109.525 | 428.579 | 81.402 | 33.237 | 33.976 |
Cash | - | - | 182 | 4.606 | 9.832 | 133.450 | 2.749 | 61.078 | 463 | 355.763 |
Shareholders Funds | - | - | 89.696 | 85.235 | 88.683 | 195.717 | 408.360 | 172.335 | -30.207 | 247.087 |
Social Capital | - | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | 0 | 1.459 | 2.097 | 103.861 | 69.600 | 5.197 | 137.455 | 160.192 |
Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4221 - 4221" | |||||||||
CAEN Financial Year |
4221
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Anmed Imob Srl